Assessment of factors that contribute to decreased quality of life in gynecologic oncology group ovarian cancer trials

INIS

• cancer 50%
• women 50%
• ovaries 50%
• assessments 41%
• quality of life 33%
• patients 25%
• therapy 25%
• comparative evaluations 16%
• symptoms 16%
• levels 8%
• surgery 8%
• management 8%
• interventions 8%
• pain 8%
• side effects 8%
• chemotherapy 8%
• sex 8%
• nausea 8%

Medicine and Dentistry

• Woman 100%
• Patient 50%
• Functional Assessment 25%
• Ovarian Cancer 25%
• Cancer Therapy 25%
• Gynecological Oncology 16%
• Symptom Management 16%
• Surgery 8%
• Paclitaxel 8%
• Psychosocial Care 8%
• Cisplatin 8%
• Pain 8%
• Physical Well-Being 8%
• Emotional Well-Being 8%
• Clinical Intervention 8%
• Life 8%
• Assessment 8%
• Therapeutic Procedure 8%
• Sex 8%

Nursing and Health Professions

• Quality of Life 25%
• Functional Assessment 25%
• Ovary Cancer 25%
• Cancer Therapy 25%
• Quality of Life Assessment 16%
• Surgery 8%
• Side Effect 8%
• Nausea 8%
• Chemotherapy 8%
• Pain 8%
• Paclitaxel 8%
• Psychosocial Care 8%
• Cisplatin 8%
• Symptom 8%